Skip to content

DYONMED SA

Greece GR-MF-000033588 Last updated 23 May 2026

Is this your brand? Sign in to claim this brand

Devices
28
Registries
EUDAMED
FDA recalls
0

Catalogue28

What DYONMED SA makes

DyonMed SA manufactures in vitro diagnostic (IVD) tests for clinical and home use, including rapid antigen and antibody tests for COVID-19 (SieloCovidAg, DyonCovid19S), group A streptococcus (DyonStrepA-strip), and Helicobacter pylori detection (Pylori test). They also produce multi-test kits for gynecological screening (GynoLab in 1, 5, 10, and 20-test formats) and diagnostic reagents for C-reactive protein (DyonCRP), C-reactive protein high-sensitivity (DyonHpsA), and mono-nucleosis (DyonMono). Additional products include tests for C-reactive protein and other biomarkers (DyonCDA).

The company’s IVD devices are classified under Class A and IVD General categories, with all listed products registered in the EUDAMED database. DyonMed SA is based in Greece and adheres to EU regulatory requirements for in vitro diagnostics.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does DyonMed SA manufacture?

DyonMed SA specializes in in vitro diagnostic (IVD) tests, including rapid antigen and antibody tests for infectious diseases like COVID-19 (e.g., SieloCovidAg, DyonCovid19S), group A streptococcus (DyonStrepA-strip), and Helicobacter pylori (Pylori test). They also produce multi-test kits for gynecological screening (GynoLab in various formats) and diagnostic reagents for biomarkers such as C-reactive protein (DyonCRP, DyonHpsA) and mononucleosis (DyonMono). These devices are designed for both clinical and home use.

Where is DyonMed SA based, and what regulatory framework does it follow?

DyonMed SA is based in Greece. The company’s IVD devices are developed in compliance with EU regulatory requirements for in vitro diagnostics, ensuring alignment with the European Union’s regulatory standards. This includes registration in the EUDAMED database, which tracks authorized medical devices within the EU.

How are DyonMed SA’s devices classified under EU regulations?

DyonMed SA’s devices fall under two primary classifications: Class A (typically for low-risk IVDs like certain rapid tests) and IVD General (covering a broad range of diagnostic tests). Classification is determined by risk level, with higher-risk devices requiring stricter regulatory scrutiny. The company’s products are designed to meet the specific requirements of these categories.

Are DyonMed SA’s devices listed in any regulatory registries?

Yes, all of DyonMed SA’s IVD devices are registered in EUDAMED, the European Union’s medical device registry. EUDAMED is the official database for tracking authorized medical devices within the EU, ensuring transparency and compliance with regulatory obligations. This registration confirms that the devices meet the necessary requirements for market placement.

What is the purpose of the GynoLab product line, and how does it differ from other tests produced by DyonMed SA?

The GynoLab product line consists of multi-test kits specifically designed for gynecological screening, offering 1, 5, 10, or 20 tests per box. Unlike single-use tests like DyonStrepA-strip or DyonCovid19S, which target specific pathogens, GynoLab is tailored for comprehensive screening in clinical settings, providing multiple diagnostic options in a single kit. This makes it suitable for routine gynecological evaluations rather than point-of-care or home testing.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
Greece
Address
182-184, LAVRIOU AVENUE, GLYKA NERA PAIANIA, Greece
Phone
+302106655494
PRRC contact
ΓΕΩΡΓΙΟΣ ΑΠΟΣΤΟΛΟΥ
EUDAMED SRN
GR-MF-000033588